[Screening of blood donors for the prevention of post-transfusion hepatitis by means of gamma-glutamyl transpeptidase determination].
The authors describe the application for determining gamma-glutamyl-transpeptidase (GGTP) activity in donors in order to prevent posttransfusion hepatitis. They particularly refer to the high susceptibility of this method for detecting latent and chronic liver diseases virtually unable to be recognized by other methods. Regular GGTP screening having been introduced in the past 4 years, a rapid lowering of the occurrence of posttransfusion hepatitis could be observed. The authors recommend this method of examination as a valuable aid to the prophylaxis of hepatitis transferred by blood preparations.
D006505:Hepatitis / Q000209:etiology / Q000517:prevention & control*; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D065227:Transfusion Reaction; D005723:gamma-Glutamyltransferase / Q000378:metabolism*
D006511:Hepatitis B Antigens; D005723:gamma-Glutamyltransferase
Screening mittels Bestimmung der Gamma-Glutamyl-Transpeptidase bei Blutspendern zur Prävention der Posttransfusionshepatitis.